Cooke, E D <br/><br/>
Treatment of severe Raynaud's syndrome by injection of autologous blood pretreated by heating, ozonation and exposure to ultraviolet light (H-O-U) therapy.  [electronic resource] 

 -  International angiology : a journal of the International Union of Angiology  Dec 1997 
 - 250-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0392-9590 
<br/><br/><label>Subjects--Topical Terms: </label><br/>6-Ketoprostaglandin F1 alpha--blood<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Bacterial Proteins<br/>Blood--drug effects<br/>Blood Flow Velocity<br/>Blood Transfusion, Autologous--methods<br/>Chaperonin 60<br/>Chaperonins--blood<br/>Enzyme-Linked Immunosorbent Assay<br/>Hot Temperature--therapeutic use<br/>Humans<br/>Laser-Doppler Flowmetry<br/>Middle Aged<br/>Ozone--therapeutic use<br/>Raynaud Disease--blood<br/>Syndrome<br/>Ultraviolet Rays